[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Medicated Skin Care in Indonesia

February 2012 | 35 pages | ID: M347B60FFF4EN
Euromonitor International Ltd

US$ 990.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The majority of medicated skin care sales continue to be made by middle-to upper-income consumers. Meanwhile, the majority of Indonesians who belong to low-income groups still find the price of medicated skin care products too expensive, and generally leave initial symptoms of skin problems untreated. In fact, many low-income demographics have little awareness of the presence of some medicated skin care products to treat their conditions in the first place.

Euromonitor International's Medicated Skin Care in Indonesia report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2007-2011, allowing you to identify the sectors driving growth. Forecasts to 2016 illustrate how the market is set to change.

Product coverage: Allergy Eye Care, Antihistamines/Allergy Remedies (Systemic), Antiparasitics/Lice (Head and Body) Treatments, Antipruritics, Cold Sore Treatments, Combination Products - Cough, Cold and Allergy (Hay Fever) Remedies, Cough Remedies, Decongestants, Diarrhoeal Remedies, First Aid Kits, Gauze, Tape and Other Wound Care, Haemorrhoid Treatments, Hair Loss Treatments, IBS Treatments, Indigestion and Heartburn Remedies, Laxatives, Medicated Confectionery, Medicated Shampoos, Motion Sickness Remedies, Nappy (Diaper) Rash Treatments, NRT Gum, NRT Inhalators, NRT Lozenges, NRT Patches, Other NRT, Paediatric Cough, Cold and Allergy Remedies, Paediatric Digestive Remedies, Paediatric Medicated Skin Care, Pharyngeal Preparations, Standard Eye Care, Sticking Plasters/Adhesive Bandages, Systemic Analgesics, Topical Allergy Remedies/Antihistamines, Topical Analgesics/Anaesthetic, Topical Antifungals, Topical Germicidals/Antiseptics, Vaginal Antifungals.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
  • Get a detailed picture of the Medicated Skin Care market;
  • Pinpoint growth sectors and identify factors driving change;
  • Understand the competitive environment, the market’s major players and leading brands;
  • Use five-year forecasts to assess how the market is predicted to develop.
Euromonitor International has over 30 years experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago and Sydney and a network of over 600 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.
Headlines
Trends
Switches
Competitive Landscape
Prospects
Category Data
  Table 1 Sales of Medicated Skin Care by Category: Value 2006-2011
  Table 2 Sales of Medicated Skin Care by Category: % Value Growth 2006-2011
  Table 3 Medicated Skin Care Company Shares by Value 2007-2011
  Table 4 Medicated Skin Care Brand Shares by Value 2008-2011
  Table 5 Forecast Sales of Medicated Skin Care by Category: Value 2011-2016
  Table 6 Forecast Sales of Medicated Skin Care by Category: % Value Growth 2011-2016
Kalbe Farma Tbk Pt in Consumer Health (indonesia)
Strategic Direction
Key Facts
  Summary 1 Kalbe Farma Tbk PT: Key Facts
  Summary 2 Kalbe Farma Tbk PT: Operational Indicators
Company Background
Production
Competitive Positioning
  Summary 3 Kalbe Farma Tbk PT: Competitive Position 2011
Tempo Scan Pacific Tbk Pt in Consumer Health (indonesia)
Strategic Direction
Key Facts
  Summary 4 Tempo Scan Pacific Tbk PT: Key Facts
  Summary 5 Tempo Scan Pacific Tbk PT: Operational Indicators
Company Background
Production
  Summary 6 Tempo Scan Pacific Tbk PT: Production Statistics 2011
Competitive Positioning
  Summary 7 Tempo Scan Pacific Tbk PT: Competitive Position 2011
Executive Summary
Burgeoning Economy Facilitates Faster Growth of Consumer Health
Climate Change Leads To Increased Demand for Consumer Health Products
2011, A Better Year for Domestic Players
Hypermarkets, Supermarkets and Chemists/pharmacies Increase Their Role
Growth To Remain Respectable in the Forecast Period
Key Trends and Developments
Improved Economic Conditions Lead To Accelerating Value Growth
Companies Make Use of the Phenomenal Growth of Social Networking Websites
Products Targeted at the Ageing Population Are on the Rise
More Local Companies Engage in Corporate Social Responsibility Programmes
Climate Changes Lead To Increased Demand for Several Consumer Health Products
Market Indicators
  Table 7 Consumer Expenditure on Health Goods and Medical Services 2006-2011
  Table 8 Life Expectancy at Birth 2006-2011
Market Data
  Table 9 Sales of Consumer Health by Category: Value 2006-2011
  Table 10 Sales of Consumer Health by Category: % Value Growth 2006-2011
  Table 11 Consumer Health Company Shares 2007-2011
  Table 12 Consumer Health Brand Shares 2008-2011
  Table 13 Sales of Consumer Health by Distribution Format: % Analysis 2006-2011
  Table 14 Sales of Consumer Health by Category and Distribution Format: % Analysis 2011
  Table 15 Forecast Sales of Consumer Health by Category: Value 2011-2016
  Table 16 Forecast Sales of Consumer Health by Category: % Value Growth 2011-2016
Appendix
OTC Registration and Classification
Vitamins and Dietary Supplements Registration and Classification
Self-medication/self-care and Preventative Medicine
Switches
  Summary 8 OTC -Switches 2009-2011
Definitions
  Summary 9 Research Sources


More Publications